FGP
OSCR icon

Freestone Grove Partners’s Oscar Health OSCR Stock Holding History

Freestone Grove Partners’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,602,569
Closed -$18.4M – 1246
2026
Q1 		$18.4M Buy
1,602,569
+1,093,633
+215% +$15.4M 0.13% 219
2025
Q4 		$7.31M Buy
+508,936
New +$8.8M 0.05% 318

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Freestone Grove Partners's OSCR Position: Q2 2026 in Review

Freestone Grove Partners sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 1,602,569 shares — an estimated $18.4M sold.

Freestone Grove Partners first reported a position in OSCR in Q4 2025 and held it in 2 quarters. The position peaked at $18.4M in Q1 2026. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Freestone Grove Partners reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 1,602,569 Oscar Health shares in Q2 2026, an estimated $18.4M.
  • Freestone Grove Partners first reported a position in Oscar Health in Q4 2025 and held it in 2 quarters.
  • Freestone Grove Partners's Oscar Health position peaked at $18.4M in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.